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This paper is concerned with  conditions required  for the growth of a  trans- 
planted  benign  mammary  tumor  of  the  rat  and  with  the  identification  of 
hormones which accelerate  its growth in animals  deprived  of the  ovaries and 
the hypophysis. The mammary glands  of these  rats  are atrophic yet grow in 
the presence  of  certain  hormones and  so permit  the  study in parallel  of  the 
growth of the tumor and of the breast of its host. Do these closely related  tis- 
sues respond identically to hormonal stimulators  of growth? 
Fibroadenomas of the mammary gland of the rat are neoplasms which have long 
been known. They have large interest  because of typical distinctive peculiarities  to 
be described. They have certain functional characteristics of their tissue of origin so 
that  their growth is profoundly influenced by the administration  or withdrawal  of 
appropriate  hormones;  in  these  ways  the  tumors  resemble  certain  cancers  of  the 
human breast. The fibroadenoma is readily transplantable to other rats where, under 
favorable conditions, it grows to large size in a few months. Much difficulty has been 
encountered in earlier work in the standardization of the growth of this tumor, and 
it has led  to contradictory statements  concerning the effects of hormones upon its 
growth. In the present  experiments  some progress was made in  the conduct of the 
experiments so that the effect of endocrine modifications on the growth of the tumor 
has become reproducible, permitting  the recognition of growth-promoting agents. 
The  effect of hormones  on  established  cancers  of  the  breast  have  been  learned 
exclusively from studies of the disease in man. It is known that some of the mammary 
cancers of the human being are dependent on hormones since they regress following 
removal of  the  ovaries  (1),  the  adrenal  glands  (2),  or  the hypophysis  (3,  4).  The 
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hormones which are critical in the maintenance and propagation of these hormone- 
dependent neoplasms have not been identified. In contrast to such human  cancers, 
the mammary carcinomas of animals usually are so undifferentiated that they have 
lost the responsiveness to hormonal changes which is characteristic of the mammary 
gland itself, hence the need for a more reactive tumor for experimental purposes. It 
will be shown  that  the benign  tumor employed in  the present experiments fulfills 
many of the laboratory requirements and so constitutes a useful experimental model. 
Mammary fibroadenoma develops in nearly 50 per cent of female rats of the Sprague- 
Dawley strain (5). It seldom arises before the age of 18 months (6) and has not been 
observed in males. 
Mammary  fibroadenoma of  the  rat  can  undergo  changes  in  its structure  after 
hormonal stimulation. Loeb and Fleisher (7) were the first to transplant this tumor 
to other rats and they discovered that pregnancy stimulated its growth. Heiman (8) 
confirmed these findings and observed a milky secretion in the tumor in pregnant rats. 
Emge and Murphy (9) likewise found that during pregnancy the adenomatous element 
of  the  tumor  underwent  hyperplasia and  that  it  secreted milk after  parturition. 
Heiman and Krehbiel (10) were the first workers to discover that ovariectomy retards 
the growth of the tumor. 
In earlier work the effects of hormones on the growth of the fibroadenoma have 
been measured in 2 ways: (a) the percentage of transplants which grew; (b) the time 
required for the tumor to attain sizes which were arbitrarily selected (12). 
In normal adult females the incidence of "takes" has ranged from 42.7 to 75 per 
cent of the animals (10-11). These values are considerably lower than  those to be 
reported in the present paper. The number of "takes" is greater in normal females 
than in gonadectomized rats of either sex or adult males (10-12). 
In addition to calculating the percentage of "takes," Millar and Noble (12) meas- 
ured the diameters of the tumor and determined thereby the "latent" and "growth" 
periods of the tumor; they noted an inconsistency of response for all of these criteria. 
It has been reported that relatively small amounts (1 to 10 ~g. daily) of estrogenic 
substances have no effect on the tumor in female rats. The estrogens employed were 
estrone (13,  14), diethylstilbestrol (15),  and estradiol (15).  Mohs  (11), on the con- 
trary, stated that estrone increased the number of successful transplants. Large doses 
of  diethylstilbestrol (100  to  200  /~g. daily)  caused  retardation  or  arrest of  tumor 
growth (15); this inhibition of growth was not related to the decreased intake of food 
induced by estrogenic substances since the growth rate of  the tumor was not de- 
pressed by underfeeding (16). 
It has been  stated  that  progesterone in  small amounts  retarded  the  growth  of 
the tumor (17) while in larger dosage it exerted no effect (15). 
Crude extracts of the pituitary accelerated the growth of the tumor, but a refined 
preparation of growth hormone did not alter its growth rate  (15).  When chorionic 
gonadotrophin was injected with estrone in gonadectomized rats the growth rate of 
the  tumor  was  enhanced  but  neither  hormone  was  effective  when  administered 
separately (10). 
Methods 
The mammary fibroadenoma used in the present experiments had arisen in our laboratory 
in a female rat which had been incompletely hypophysectomized at age 25 days. The tumor c.  HUGGINS~ Y.  TORRALBA~ AND  K.  MAINZER  527 
was first observed in  the rat  at age 554  days. It was transplanted  into albino rats  of the 
Sprague-Dawley strain which were obtained from the dealer at age 42 days; they were kept 
thereafter under controlled env/ronmental conditions (18). All the rats were fed a commerlcal 
ration except those which were hypophysectomized and  these received a  high protein syn- 
thetic diet  (19).  Adrenalectomized rats  were maintained  on 0.9 per cent sodium chloride 
drinking fluid without supplemental steroids. 
The experiments were based on 17 series of rats each consisting of 106 animals. In each 
series, 16 rats were kept intact as controls and the others (9 in each group) were subjected to 
hypophysectomy, ovariectomy, or adrenalectomy at age 42  to 44 days.  Hysterectomy was 
performed in rats which were injected with large dosages of estrogenic compounds. All of the 
surgical operations and the transplantations of tumor were performed under ether anesthesia. 
The tumor was transplanted  to recipients at age 51 days. The donor in each case was an 
intact adult female bearing a  large actively growing tumor. After removal from the donor 
the tumor was  sliced and  oval fragments were cut from the slices  with a  surgical punch. 
Four pieces of tumor were implanted  subcutaneously in each inguinal and  axillary region 
through a small incision in the epigastrium. The implants measured about 3 X  2  X  2 mm. 
and weighed about 40 rag. Every tenth fragment was weighed and  the standard  deviation 
of "these weights was calculated. Many of the rats received steroids.  I These compounds were 
dissolved in ethyl alcohol which was diluted with sesame oil to make the final alcoholic con- 
centration  10 per cent. The solution (0.2 ml.) was injected subcutaneously for 6 days each 
week. Protein hormones were dissolved in a solution of 2 per cent sodium bicarbonate. Through- 
out this paper dosage refers to the amount administered each day. Each of the experiments 
described in this paper was repeated on at least 2 separate occasions. 
At necropsy  the  tumors,  uteri,  and  the inguinal  mammary  glands  were weighed on  a 
precision balance. Histological preparations of these tissues and of the vagina were stained 
with hematoxylin and  eosin.  The tumors and  the mammary glands were placed in a  large 
volume of ice cold acetone which was kept in a refrigerator for 1 day. The content of alkaline 
phosphatase and the site of this enzyme were then determined. 
After evaporation of acetone in an evacuated desiccator at room temperature  the tissues 
were homogenized and the alkaline phosphatase was determined by the method of King and 
Armstrong (20); the results are expressed in the units of these workers. 
The site of alkaline phosphatase activity in the mammary gland and the tumor was deter- 
mined by the method of Gomori (21).  The mammary glands were pressed firmly between 
sheets of filter paper to express fat; thin equatorial slices of the tumor were cut with a razor. 
The tissues were then incubated for 4 hours in calcium chloride and sodium fl-glycerophosphate 
before treatment with cobalt acetate (21). They were dehydrated in alcohol and acetone and 
rendered more transparent by immersion in dioxane and, later, methyl salicylate. They were 
then mounted between 2 sheets of acrylic plastic,  ~ I ram. in thickness, and cemented together 
with catalyzed liquid plastic. 
RESULTS 
Ten  days  after  transplantation,  the  grafts  consisted  of  a  crescentic  rim  of 
surviving  ceils  surrounding  a  dead  center  which  always  contained  a  small 
area  of calcification. At 50 days  it was  found  that  some of the grafts had  not 
I We acknowledge with gratitude gifts of steroids from Dr. E. A. Sharp, Parke, Davis & 
Co., Detroit, and Dr. H. J. Ringold, Syntex, S. A., Mexico, D. F. The protein hormones were 
generous gifts from Dr. C. H. Li, University of California, Berkeley. 
The sheets of acrylic plastic, known as plexiglas, were purchased from Rohm& Haas Co., 
Philadelphia.  The catalyst was ~-butyl hydroperoxide; the liquid plastic used, selectron, was 
obtained from Pittsburgh Plate Glass Co., Pittsburgh. 528  IIORM:0NAL IN~LI/ENCES ON M.~M-MARY TUMORS. I 
survived; these  were  pearly white  with  a  polished  surface  and were  loose  in 
the  tissues,  Most  of the  transplants  remained viable  and  grew.  The  tumors 
that  were  let  alone  reached  massive  size  in  intact  animals  killing  the  host 
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TExT-FIG.  1.  The weight of transplanted  fibroadenoma growing in intact  adult  female 
rats harvested at 10 day intervals following transplantation.  The original transplanted frag- 
ments weighed 24 ~  7 mg. The weight of each individual tumor •  and the mean values © 
are given. Ordinates, weights of the tumors plotted logarithmically. Abscissae,  time in days. 
some 3 to 6 months after transplantation. Necrosis was very rare and metastases 
were never observed. In an hypophysectomized  rat the adenomatous component 
of one of the  tumors changed to a  carcinoma 20 days after  transplantation; 
no  sarcomas  or  pure  fibromas were  detected.  The  transplants  did  not  grow 
unless epithelial cells were present. C.  HUGGINS~  Y.  TORRALBA,  AND  K.  MAINZER  529 
In intact rats the tumor consisted of a  collection of spheroids with an en- 
cLrcling network of capillaries. In normal female rats each spheroid consisted 
of a canal system of ducts (Fig. 1) surrounded by fibroma cells. 
The tumor contains considerable quantities of alkaline phosphatase  which 
is present both in the epithelial cells and in the capillaries (Figs. 2, 3); this net- 
work of capillaries was far more extensive in rapidly growing tumors (Fig. 4) 
than in those whose growth rate was slower (Fig. 2). In the mammary gland 
this  enzyme was  demonstrated  in  the  capillaries  merely in  small  amounts 
(Fig. 5) and the chief concentration was in the epithelial cells. 
In  103  normal  adult  female  rats  the  implants  grew  in  98  animals  (95.1 
per cent takes)  in a  consecutive series of transplantations;  tumors developed 
in each of the last 60 rats implanted. The weight of all of the surviving grafts 
TABLE I 
Effect of Remeoal o/Endocrine  Glands on Growth of Fibroadenoma and the Alkaline Phosphatase 
Content oJ the Inguinal Mammary Gland 
There were 9 rats in each group. Necropsy was performed 50 days after transplanting 
except in 1 group of hypophysectomized  rats. A indicates the gain in body weight. 
Mean tumor  Alkaline  phosphatase 
Status  A  weight  of  mammary gland 
Intact 
Ovariectomy 
Ovariectomy-Adrenalectomy 
Hypophysectomy 
Hypophysectomy,  90 days 
gttt. 
113 
163 
102 
10 
9 
mg. 
54O 
182 
109 
34 
480 
units* 
1.16 -4- 0.17 
0.52  -4- 0.1 
0.45  4- 0.2 
0.09 .4- 0.03 
0.11  4-  0.02 
* King-Armstrong (20) units with standard deviation. 
in a typical  series  is shown in Text-Fig. I. Not all the transplants  grew in 
every rat;  neither did all of them grow to the same size  at an identical  rate. 
In intact  adult females autopsied at intervals  of 10 days it was found that the 
mean of the weights of the tumors increased  at a logarithmic rate (Text-Fig. 
I). There was no latent period of growth. The logarithmic rate of growth 
was apparent in each of the 4 series  of experiments of this  kind. 
Effect of Removal of Endocrine Glands 
The extirpation of endocrine glands exerted a profound effect on the growth 
of mammary fibroadenoma (Table I). Whilst  the tumor grows well in intact 
adult females, ovariectomy resulted in a  decrease in size and  the removal of 
the adrenals in addition to the ovaries caused an additional diminution. For 
50 days the content of alkaline phosphatase of the mammary glands  ran in 
parallel to the effects of the surgical procedures on tumor weight.  In intact 
rats at 50 days the epithelial cells of the tumor were relatively larger (Fig. 6) 530  HOR.~ONAL  INFLUENCES  ON  MAMMARY  TUMORS.  I 
and there was more fibromatous stroma than in tumors growing in the ovariec- 
tomized females (Fig. 7). 
The tumor grew slowly in hypophysectomized rats for about 70 days when a 
considerable increase in its growth rate occurred. At 50 days, during the period 
of indolent growth,  the  tumors of hypophysectomized (Fig.  8)  and ovariec- 
tomized rats (Fig. 7) were cytologically similar; the epithelial cells were small 
and the stroma was sparse. At 90 days, when the tumor was growing rapidly 
it resembled histologically (Fig. 9)  the cells  of tumors from intact adult fe- 
males (Fig. 6).  There was no change in body weight during the period of ac- 
celerated growth  and,  further,  the  vagina and uterus  remained in  the  pro- 
foundly atrophic  state  of  hypophysectomized rats  which  did  not  bear  the 
tumor; these findings constitute evidence that the tumor, during its period of 
active growth, does not secrete significant amounts of growth or steroid hor- 
mones. 
Effects  of Estrogenic Phenols.--Five  phenolic  estrogens were  administered 
to ovariectomized rats in amounts which induced keratinization of the vagina. 
Each of these phenols exerted biphasic effects on the growth of the fibroade- 
noma. With progressive increments of dosage there was first an augmentation 
of size of the tumor until a growth peak (Text-fig. 2) was achieved with optimal 
amounts of the compound and then there was a profound decrease in size of the 
tumor when these quantities were exceeded. 
Here are the amounts of phenolic estrogens which induced optimal tumor 
growth: estradiol-17/3,  0.1  gg.; estrone, 1 /~g.; estriol, 10 to 20 gg.; estradiol- 
3,16a,  50  /~g. The tumors of animals injected at these optimal dosage levels 
were larger than those of their uninjected intact sisters. The cytology  was iden- 
tical in all groups: there was growth of the ducts of the  tumor without the 
formation of alveoli. 
The  following  dosages  of  estrogenic  phenols  profoundly  depressed  the 
growth of the  tumor: estradiol-17]3,  20 gg.; estrone, 50/~g.;  estriol,  100 ~g. 
Diethylstilbestrol (10 rag.) implanted subcutaneously in pellet form caused a 
similar depression. The tumors in rats so treated were smaller than those of 
uninjected control rats subjected to hypophysectomy. These tiny tumors con- 
tained ducts embedded in fibromatous stroma and many of the ducts contained 
small quantities of milk. There was no prolactational proliferation. Necrosis 
was  not observed.  Rats  injected with increasing  doses of  these  compounds 
suffered  the  progressive  retardation  of  body  growth  which  is  induced  by 
phenolic estrogens (22). 
There  were  only subtle  architectural changes in  the mammary glands  of 
ovariectomized  rats  injected  with  optimal  amounts  of  phenolic  estrogens. 
These consisted of a  slight widening of the ducts, but alveoli did not develop 
(Fig. 5). The dilatation of the ducts increased with larger doses of these estro- 
genic phenols. With  the biggest amounts,  large  cysts filled with  milk  were 
seen along the ducts; this effect has been described earlier (23). C. HUGGINS, Y. TORRALBA, AND K. MAINZER  531 
The  administration  of small amounts  of phenolic  estrogens  caused  a  pro- 
gressive rise in the content and concentration (Text-fig. 2) of alkaline phospha- 
tase in the mammary gland and this increment was monophasic. The estrogens, 
even in the largest dosages employed, did not retard growth of the mammary 
gland. 
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TEXT-FIG. 2. Increasing doses of estfiol in ovafiectomized rats caused (a) a biphasic effect 
on the growth of mammary fibroadenoma, (b) a progressive increase of alkaline phosphatase 
in the mammary gland, and (c) retardation in the gain of body weight. Ordinates on the left 
indicate the mean weight of the  tumor in milligrams whi]e A  indicates the gain in body 
weight in grams during the experiment. Ordinates on the fight indicate the alkaline phos- 
phatase concentration in the mammary gland expressed in King-Armstrong units per  I00 
rag. of fat-free dry weight. 
A~rostane  Derivati~es.--Several  related  compounds  (Table  If)  in  the 
adrostane  series  were  injected  into  ovariectomized rats  bearing  the  trans- 
planted tumor. These steroids have the common property of inducing growth 
of the ventral prostate of the female rat but their selection was prompted by 
physiologic  differences  which  these  compounds  exert  in  eliciting  growth  of 
other target organs. 
19-Nor-ethinyl-testosterone  reproduced  many  of  the  systemic  effects  of 
pregnancy and  there was a  moderate growth  of the vestigial prostate.  There 
was  gestational  mucification  of  the  vagina  and  intense  prolactational  pro- 
liferation  of the  epithelium  of the  breast.  The  compound  elicited  growth  of 532  HORMONAL  INFLUENCES  ON MAMMARY  TUMORS. I 
the uterus. The rats receiving this compound (Table H) developed the largest 
tumors encountered in these experiments. The fibroadenoma was characterized 
by the proliferation  of ducts to form lobules;  similar  changes  in the tumor 
occur in ovariectomized rats injected with estrone and progesterone. 
The estrogenic  alcohol,  5-androstene-3/~,lT~-diol  elicited  keratinization of 
vagina and growth of the uterus but caused only a slight acceleration of growth 
of the fibroadenoma.  The  growth of the mammary glands  was  also  slight. 
5-Androsten-3/~-ol-17-one did not modify the growth of the tumor. 
Three steroids caused striking growth of the prostate and of the mammary 
glands and elicited vaginal mucification. These compounds were 4-androstene- 
TABLE  II 
Effect  of Steroids  in the Androstane  Series  on Growth of Mammary Fibroadenoma  in 
Ovarieetomized Rats 
The steroids, 1 rag. daily, were injected for 50 days with 9 rats in each group. A indicates 
the gain in body weight during the experiment. 
Compound 
19-aYor-ethinyl testosterone 
Intact-uninjected 
5-Androstene-3~, 17#-diol 
4-Androstene-3~, 17#-diol 
4-Androstene-3/3,17#-diol 
Ovariectomy-uninjected 
S-Androsten-3~-ol-I  7-one 
Testosterone 
Mean 
A  tumor 
weight 
gra.  mg. 
79  750 
116  242 
164  99 
177  67 
167  63 
172  59 
169  57 
145  50 
Uterus 
mg. 
336 
461 
329 
473 
286 
37 
81 
513 
Ventml prostate 
Incidence Weight* 
2/8  22 
0 
5/9  80 
5/9  288 
3/9  126 
0 
1/9  14 
4/9  138 
Vaginal 
epithelium 
Progestational 
Keratin 
Mucus 
Mucus 
Atrophy 
Stratified 
Mucus 
* Mean values. 
3a, 17/3-diol, 4-androstene-3/3,17fl-diol, and testosterone.  The nipples  became 
red and considerably  enlarged  and the ducts became dilated. There was pro- 
lactational proliferation  of  the  mammary epithelium which  was  especially 
developed  in rats injected with 4-androstene-3a,17/3-diol.  These compounds 
did not accelerate the growth of the tumor in ovariectomized rats (Table II). 
Progesterone.--Progesterone,  2 to 4 mg., administered alone to ovariectomized 
rats, stimulated the growth of the tumor (Table III) but doses of 1 mg. were 
ineffective. No growth of the mammary gland was detected in these rats and 
the vaginal epithelium remained in an atrophic state. 
Progesterone, 1 to 4 mg., enhanced the growth of the tumor in ovariectomized 
rats treated simultaneously  with either small or large doses of phenolic estro- 
gens as is shown in Table III. The suppression of growth of the tumor, which 
is brought about by large amounts of phenolic estrogens was partly overcome C.  HUGGINS,  Y, TORRALBA~ AND K. MAINZER  533 
by simultaneous administration of progesterone, 1 to 4 mg. Both the mammary 
glands and the fibroadenoma of rats treated with these hormones in combina- 
tion had the characteristic proliferative effects seen in pregnancy. 
Pituitary  Proteins.--Certain  highly  refined  hormones  isolated  from  the 
pituitary were injected into hypophysectomized rats in which the mammary 
fibroadenoma  had  been  implanted.  These  proteins  were  growth  hormone, 
0.25 to 0.5 rag., lactogenic hormone, 1 rag., and adrenocorticotrophin (ACTH), 
4 units. Injected separately none of these hormones accelerated the growth of 
the  tumor  (Table IV).  In rats  injected with growth  or lactogenic hormones 
the size of the fibroadenomas was identical with that of the tumors of unin- 
jected hypophysectomized control rats. 
TABLE III 
Effect of Progesterone  and Phenol~ Estrogens on Gromth of Mammary Fibroadenoraa in 
Ovarieetoraized Rats 
The steroids were injected for 50 days and there were 9 rats in each group, zX indicates 
the gain in body weight during the experiment. 
Progesterone,  Mean tumor  Phenolic estrogen, daily dosage  dosage  /~  weight 
Estriol, 20/~g. 
Estriol, 20 gg. 
Estrone,*  100 ttg. 
Estrone,*  100/tg. 
Ovariectomy 
Ovariectomy 
Ovariect omy--uninjected 
rag. 
1 
o 
4 
o 
4 
1 
o 
99 
97 
89 
71 
183 
197 
172 
mg. 
1828 
521 
259 
53 
I133 
61 
53 
* Hysterectomy and ovariectomy. 
Tests were made for the potency of these proteins. The increase in  body 
weight (Table IV) showed that the growth hormone was physiologically active. 
It was known from other experiments that our sample of lactogenic hormone 
was  capable of inducing  lactation in  the mammary glands of dogs and rats 
injected earlier with estrone and progesterone. The combined adrenal weight 
of the  rats  injected with ACTIt increased to  24 rag.  whereas in  uninjected 
hypophysectomized rats the adrenals weighed 8 rag. on average. 
Neither estrone 1 #g. nor progesterone 1 mg., injected separately, caused an 
increase of size of the tumor in hypophysectomized rats. A considerable increase 
of tumor size ensued when these steroids were injected together. The injection 
of growth hormone, 0.5  rag.,  or of lactogenic hormone 1 mg.,  together with 
both estrone and progesterone effected an additional,  though slight,  increase 
of weight of the tumor. 
In  hypophysectomized rats,  the morphology of the mammary glands  was 534  HOP.MONAL  IIN'FLUENCES  ON  MAMI~ARY  T~ORS.  I 
unmodified by the injection, separately, of estrone 1/~g. (Fig. 11), progesterone 
1 mg. (Fig.  12),  lactogenic hormone 1 rag. or ACTH 1 or 4 units. The charac- 
teristic slender duct system (Fig.  10)  of the mammary glands of hypophysec- 
tomized rats persisted despite the injection of these hormones. The combina- 
tion  of  estrone  and  progesterone  induced  slight  growth  of  the  mammary 
gland (Fig. 13)  while growth of the tumor was much stimulated. 
Growth hormone 0.25  to 0.5 mg., alone or in combination with estrone and 
progesterone  caused  proliferation  of  the  ducts  with  the  formation  of  acini 
along the mammary tree (Figs.  14 and 15). 
TABLE IV 
Effect of Steroids  and  Pituitary  Hormones  on  Growth  of Mammary  Fibroadenoma  Sn 
ttypopkysectomized Rats 
The hormones were injected for 50 days and there were 9 rats in each group. A indicates 
the gain in body weight during the experiment. 
Hormones 
Intact; no injections 
Estrone 1 t*g. +  progesterone 1 rag. +  lactogenic hormone 
1 rag. 
Estrone 1 ~g. +  progesterone 1 rag. +  growth hormone 0.5 
mg. 
Estrone 1 ~g. +  progesterone 1 rag. +  ACTH, 4 units 
Estrone 1 ~g. +  progesterone 1 nag. 
Estrone 1 ~g. 
Growth hormone 0.5 rag. 
Progesterone I rag. 
Lactogenic hormone 1 mg. 
Hypophysectomy only 
ACTH, 4 units 
A 
gm. 
78 
0 
15 
7 
77 
17 
11 
8 
--4 
erus 
52 
57 
41 
41 
34 
80 
41 
18 
13 
18 
18 
Tumor 
weight 
rag. 
318 
164 
139 
118 
107 
51 
48 
47 
47 
47 
20 
DISCUSSION 
Quantitative  studies  of  metabolic  activity  in  the  non-pregnant  or  non- 
lactating mammary gland of the rat present unusual  difficulties.  Each breast 
of the normal adult rat consists of a few delicate tubules which ramify diffusely 
in a  large pad of fat. The determination of the content  and concentration of 
alkaline phosphatase proved to be a useful quantitative indicator of hormonal 
response by the epithelial cells of the mammary gland. The methods are simple 
and reproducible. The values were easily correlated with the site of the enzyme 
as  determined  histochemically.  The  principal  locus  of  this  enzyme  is  the 
epithelial cells; the phosphatase-containing capillaries of the intact mammary 
gland are few. 
A critical test for any proposed chemical method for determining the effects C. HUGGINS, Y. TORRALBA, AND K. ~[AINZER  535 
of hormones on growth of the mammary gland is its success  in distinguishing 
between the glands of intact and ovariectomized adult females. The extirpa- 
tion of certain endocrine glands resulted in great differences in the values of 
alkaline phosphatase  in  the breast.  The mammary glands of intact females 
have a  significantly higher phosphatase  content than those of their ovariec- 
tomized sisters  whilst  the  breasts  of hypophysectomized rats  contain  only 
small  amounts  of  the  enzyme. Moreover,  phenolic  estrogens  increase  the 
amount of alkaline phosphatase in the mammary glands of ovariectomized rats. 
Under hormonal conditions favorable to  the growth of the tumor, such as 
exist  in  the  intact  adult  female,  the  incidence  of  successful  transplants  of 
fibroadenoma approaches  100 per cent of the animals and there is no latent 
period  of growth.  Some of the grafts die  however and the  surviving trans- 
planted fragments do not grow at  a  uniform rate.  But  the use of multiple 
transplants permits the accumulation of a considerable number of tumors in a 
series of 9 rats and, with this the case,  the weight of the grafts on the average 
indicates that  the  tumor grows at a  logarithmic rate.  The lack of precision 
precludes valid deductions drawn from small differences in mean tumor weight. 
Effects of large magnitude were repeatedly confirmed in repeated experiments; 
and only these are under discussion. 
The most consistent results  were obtained when  the  tumors subjected  to 
experiment were harvested at a  time when one of the diameters of the tumors 
in intact adult females was  about  1 cIn.  Tumors of this  size  then weighed 
about 0.5 to 1 gin. 
To ascertain the effects of hormones on the growth of mammary neoplasms 
through experimentation is it necessary to study a mammary tumor, or is the 
non-neoplastic mammary gland adequate? It appears that neoplastic cells are 
required. True, there are similarities in the effects of hormones on the growth 
of  both  mammary gland  and  mammary fibroadenoma,  but  significant dif- 
ferences of response exist. 
To cite some of the similarities, small amounts of estrogenic phenols induce 
growth both in mammary gland and tumor and large amounts of these sub- 
stances bring on lactation in each. In both tissues progesterone enhances the 
growth-promoting properties of estrogenic substances. 
The differences of action of hormones on mammary gland and fibroadenoma 
are many and striking. (a) Progesterone administered alone to ovariectomized 
rats had no demonstrated effect on the mammary gland but it accelerated the 
growth of the tumor. (b) With increasing dosage of phenolic estrogens biphasic 
effects on the growth of the fibroadenoma were observed; the effect of these 
compounds on the mammary glands of the host of the tumor was monophasic 
comprising stimulation only, without subsequent depression of growth of the 
breast.  (c)  In  hypophysectomized  rats,  estrone  and  progesterone  induced 
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gland.  (d)  Growth  hormone,  administered alone,  caused  the  formation of 
alveoli along the mammary ducts of hypophysectomized  rats but did not ac- 
celerate growth of the tumor. 
Yet another important difference between the growth of the tumor and the 
mammary gland was observed in hypophysectomized rats. Following a period 
of many weeks wherein  growth of the  tumor was  not  apparent,  the fibro- 
adenoma increased in size and eventually becomes large, but there is no as- 
sociated  growth in the mammary gland.  During the time of quiescence the 
tumor was atrophic but during active growth it is identical  cytologically with 
fibroadenomas in intact, adult females. Profoundly influenced by the presence 
of certain steroids  in the organism,  the tumor acquires  the ability to grow 
actively in hypophysectomized rats wherein the presence of these compounds 
cannot be  detected by biological means.  The epithelium  of the vagina is a 
sensitive indicator (18) of the presence of growth-promoting  steroids,  and its 
cells remain atrophic. 
In  hypophysectomized  rats  estrone  and  progesterone,  injected  together, 
induced  growth of  the  tumor,  and  growth hormone or lactogenic  hormone 
intensified  this growth.  None of these  hormones  administered separately in- 
duced growth in these rats. The steroid hormones exerted  a greater influence 
on growth of the tumor than the protein hormones of the pituitary but syner- 
gism existed among certain members of these classes of endocrine substances. 
The effects of steroids in inciting  growth of the tumor could not be corre- 
lated with either the amount or the kinds of growth which these compounds 
evoke in the normal organs  of the rat. Mammary fibroadenoma  apparently 
possesses characteristics  of hormonal reactivity which  are  peculiar  to  itself 
amongst the endocrine  target cells of this species. It was therefore  of note- 
worthy interest to find that all the therapeutic measures now known to retard 
mammary cancer in clinical practice  likewise retard the growth of this benign 
tumor. It would  appear  that in its endocrinologic responses  the rat  tumor 
resembles these human tumors more closely than it does the mammary gland 
of the rat. 
CONCLUSIONS 
A transplanted mammary fibroadenoma was found to grow in 95 per cent of 
intact adult female rats and the increment of tumor weights was progressive 
and logarithmic. 
The growth of the tumor was retarded by ovariectomy and still more when 
this was combined with adrenalectomy. In ovariectomized rats the growth of 
the tumor was stimulated by phenolic estrogens, this increase being enhanced 
when progesterone was added. 
In these responses to hormonal changes the mammary gland and the tumor 
resembled each other. Yet there are many differences between  the growth of C. HUGGINS~  Y. TORRALBA,  AND K. MAINZER  537 
the fibroadenoma  and that of the mammary gland.  In contrast to the pro- 
gressive growth which occurred in intact adult females there was a prolonged 
period  of  indolent  growth  of  transplants  in  hypophysectomized rats;  but 
after many weeks  active growth began and  the tumors eventually reached 
large size. During the period of quiescent growth the tumor was cytologically 
atrophic but after the growth spurt had started the microscopic appearance 
of the fibroadenoma resembled that of tumors growing in normal adult females. 
The mammary gland  remained atrophic  during both  the slow and  the ac- 
celerated  phases  of tumor growth,  and so  too  with the other secondary sex 
expressions. 
In  hypophysectomized rats  estrone  and  progesterone,  when  combined, 
stimulated the growth of the tumor, and this growth was accelerated  by the 
additional administration of lactogenic  or growth hormones.  None of these 
hormones, separately, stimulated the growth of the tumor. 
In  ovariectomized  rats  other  differences were  demonstrated between  the 
growth of the mammary gland and the fibroadenoma.  Progesterone,  injected 
alone,  accelerated  the growth of  the  tumor but  not  that of the mammary 
glands.  The  administration of  phenolic  estrogens  exerted  a  biphasic  effect 
on the growth of the tumor whilst  that on the breast of its hosts was mono- 
phasic. With progressively  increasing  doses of these  phenols  there  occurred 
primarily an augmentation of the rate of growth of the tumor until a peak was 
achieved;  an increase  of the dose  above  the optimal amount depressed  the 
growth of the tumor. The stage of depression of growth was not observed in 
the mammary glands of these tumor-bearing rats. 
Many steroids  which  induced gestational changes  in the mammary gland 
accelerated  the  growth of  the  tumor.  Among  these  were  estrone  and  pro- 
gesterone  in  combination  and  17a-ethinyl-19-nor-testosterone  administered 
alone.  But  gestational  changes  developed  in  the mammary gland  of  rats 
treated with 4-androstene-3ot, 17fl-diol, without growth of the tumor. 
The  evidence  which  we have presented proves  that the  mammary fibro- 
adenoma tested had some of the functional properties  of a normal mammary 
gland, and neoplastic  traits as well. In its response to hormones it had charac- 
teristics which set it apart from all other endocrine targets of the rat. 
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EXPLANATION OF PLATES 
PLA~E 43 
FIG. I. An equatorial slice of mammary fibroadenoma from an hypophysectomized 
rat 92 days after transplantation, showing the interlacing  duct system in a spheroid. 
The slice was stained with alum carmine.  X  120. 
FIo. 2. An equatorial slice of mammary fibroadenoma from an intact rat 50 days 
after transplantation,  showing the distribution of alkaline  phosphatase in the duct 
system and the surrounding  capillary net. The method of Gomori (21) was  used. 
×  90. 
FIC. 3. This photomicrograph shows the distribution of alkaline  phosphatase (21) 
in the capillaries and epithelium  of the ducts of a mammary fibroadenoma  growing 
in an ovariectomized  rat injected with estriol  10/~g. The arrows point to  the capil- 
laries.  ×  460. 
FIG. 4. The distribution of alkaline phosphatase in the ducts and capillaries of a 
rapidly growing fibroadenoma of a rat injected with estriol,  10/~g. X 85. 
FIG. 5. Whole mount of the mammary gland of the rat which was the host of the 
fibroadenoma shown in Figs. 3 and 4, showing the distribution of alkaline phosphatase 
in the mammary epithelium  and the capillaries. This ovariectomized  rat had been 
injected with estriol, 10/~g. for 50 days. Few capillaries are present. X 65. THE  £[OURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  43 
(Huggins el al.: Hormonal influences on mammary tumors of the rat. I) PLATE 44 
All of the sections were stained with hematoxylin and eosin. 
FIo. 6. Mammary fibroadenoma, 50 clays after transplantation  in an intact rat: The 
epithelial cells of the tumor are tall and there is an abundance of fibromatous stroma. 
X 440. 
FIG. 7. Mammary fibroadenoma, 50 days after transplantation in an ovariectomized 
rat: The epithelial cells of the tumor are atrophic and the stroma is  sparse.  X  440. 
FIo.  8.  Mammary fibroadenoma, 50  days  after  transplantation in an  hypophy- 
sectomized rat: The tumor growth was indolent at this time. Cytologically the tumor 
resembles that shown in Fig. 7.  X 440. 
FIG.  9.  Mammary  fibroadenoma,  92  days  after  transplantation  in  an  hy- 
pophysectomized rat: The tumor growth now was  active.  Cytologically the  tumor 
resembles that growing in an intact rat as shown in Fig. 6.  X 440. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  44 
(Huggins et al.: Hormonal influences on mammary tumors of the rat. I) PLATE: 45 
Whole mounts  of  the  mammary  glands  of  hypophysectomized  rats  in  which  the 
distribution  of alkaline phosphatase  is demonstrated.  In certain  cases hormones had 
been injected. The duration of the experiment in each case was 50 days. 
FIG.  10.  This hypophysectomized  rat was not injected. The ducts  are slender and 
there are no alveoli.  X  30. 
FIG. 11. From ai1 hypophysectomized  rat injected with estrone  1 ~g. No growth of 
the mammary tree is evident.  X  30. 
FIG.  12.  F:om  an  hypophysectomized  rat  injected  with  progesterone  1  rag.  No 
growth in the mammary tree is evident.  X  30. 
FIG. 13. From an hypophysectomized rat injected with estrone 1 #g. and progesterone 
1 rag. A slight growth of the ducts has occurred but alveoli have not formed.  X  30. 
FIG.  14.  From an hypophysectomized  rat injected with growth hormone, 0.25 rag. 
Growth of ducts and the presence of alveoli are evident.  X  90. 
FIG. 15. From an hypophysectomized rat injected with growth hormone, 0.25 rag., 
estrone 1 ~zg., and progesterone 1 rag. Growth has taken place in the ducts and alveoli 
are evident.  X  90. THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  45 
(Huggins el al.: Hormonal influences on mammary tumors of the rat. I) 